Emflaza
Deflazacort
| Empaquetado | Per comprimido | Precio | Ahorro | Order |
|---|---|---|---|---|
|
120 tablet
Free AirMail shipping
Hot
|
$ 5317.08
|
$ 638049.35$ 5317.08
|
$ 115787.48
|
|
|
90 tablet
Free AirMail shipping
Hot
|
$ 5606.97
|
$ 504626.90$ 5606.97
|
$ 60750.72
|
|
|
60 tablet
Free AirMail shipping
Hot
|
$ 5800.01
|
$ 348000.55$ 5800.01
|
$ 28917.87
|
|
|
36 tablet
Free AirMail shipping
Hot
|
$ 6121.64
|
$ 220379.08$ 6121.64
|
$ 5771.97
|
|
|
24 tablet
|
$ 6281.97
|
$ 150767.37$ 6281.97
|
|
| Empaquetado | Per comprimido | Precio | Ahorro | Order |
|---|---|---|---|---|
|
90 tablet
Free AirMail shipping
Hot
|
$ 6444.88
|
$ 580039.59$ 6444.88
|
$ 115859.99
|
|
|
60 tablet
Free AirMail shipping
Hot
|
$ 6960.20
|
$ 417612.26$ 6960.20
|
$ 46320.79
|
|
|
36 tablet
Free AirMail shipping
Hot
|
$ 7410.75
|
$ 266786.89$ 7410.75
|
$ 11572.95
|
|
|
24 tablet
Free AirMail shipping
Hot
|
$ 7732.22
|
$ 185573.22$ 7732.22
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.







